NCT03128073View on ClinicalTrials.gov

A Feasibility Study of Peritoneal Ultrafiltration With a Wearable Device, CLS UF, That Adds a Glucose-salt Solution to the Intraperitoneal Fluid in the Device, in Order to Maintain a Stable Intraperitoneal Osmolarity and Thereby Enhance Ultrafiltration.

NACompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

April 20, 2017

Primary Completion Date

November 30, 2017

Study Completion Date

November 30, 2017

Conditions
Ultrafiltration Failure
Interventions
DEVICE

Carry life system, ultrafiltration (CLS UF)

The addition of Glucose-salt intermittently to a volume of the intraperitoneal fluid in the device which is then returned to the subject.

Trial Locations (1)

205 02

Kidney Unit, Malmo

All Listed Sponsors
lead

Triomed AB

INDUSTRY

NCT03128073 - A Feasibility Study of Peritoneal Ultrafiltration With a Wearable Device, CLS UF, That Adds a Glucose-salt Solution to the Intraperitoneal Fluid in the Device, in Order to Maintain a Stable Intraperitoneal Osmolarity and Thereby Enhance Ultrafiltration. | Biotech Hunter | Biotech Hunter